Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Docetaxel-PNP vs Taxotere in Advanced Solid Tumors
NCT02274610Phase 1Completed
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Start
- Nov 2014
- Primary completion
- Nov 2015
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Docetaxel-PNP in solid tumor (2 arms), sponsored by Samyang Biopharmaceuticals Corporation. Primary endpoint: Area Under the Curve at 3 months. Started Nov 2014; status: completed.
02
Drugs
Docetaxel-PNP
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02274610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02274610.